Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Annals of the Rheumatic Diseases|March 6, 2015
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trialRachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitisRachel B Jones, Jan Willem Cohen Tervaert, Thomas Hauser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2018
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritisMaria Weiner, Rune Bjørneklett, Zdenka Hrušková, et al.
Annals of Internal Medicine|May 20, 2009
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trialKirsten de Groot, Lorraine Harper, David R W Jayne, et al.
BMJ Open|December 17, 2021
Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping reviewIkechi G Okpechi, Fergus J Caskey, Abduzhappar Gaipov, et al.
Clinical Kidney Journal|January 12, 2024
Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspectiveCarlo Lomonte, Michele Rossini, Jose Ibeas, et al.
Kidney International|December 21, 2024
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trialBalazs Odler, Regina Riedl, Duvuru Geetha, et al.
Molecular Systems Biology|January 4, 2024
Detection of PatIent-Level distances from single cell genomics and pathomics data with Optimal Transport (PILOT)Mehdi Joodaki, Mina Shaigan, Victor Parra, et al.
Rheumatology (Oxford, England)|December 16, 2010
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitisRavi Suppiah, Chetan Mukhtyar, Oliver Flossmann, et al.
Kidney International Supplements|March 10, 2020
Framework for establishing integrated kidney care programs in low- and middle-income countriesMarcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|March 6, 2015
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trialRachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitisRachel B Jones, Jan Willem Cohen Tervaert, Thomas Hauser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2018
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritisMaria Weiner, Rune Bjørneklett, Zdenka Hrušková, et al.
Annals of Internal Medicine|May 20, 2009
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trialKirsten de Groot, Lorraine Harper, David R W Jayne, et al.
BMJ Open|December 17, 2021
Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping reviewIkechi G Okpechi, Fergus J Caskey, Abduzhappar Gaipov, et al.
Clinical Kidney Journal|January 12, 2024
Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) program: the teachers' perspectiveCarlo Lomonte, Michele Rossini, Jose Ibeas, et al.
Kidney International|December 21, 2024
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trialBalazs Odler, Regina Riedl, Duvuru Geetha, et al.
Molecular Systems Biology|January 4, 2024
Detection of PatIent-Level distances from single cell genomics and pathomics data with Optimal Transport (PILOT)Mehdi Joodaki, Mina Shaigan, Victor Parra, et al.
Rheumatology (Oxford, England)|December 16, 2010
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitisRavi Suppiah, Chetan Mukhtyar, Oliver Flossmann, et al.
Kidney International Supplements|March 10, 2020
Framework for establishing integrated kidney care programs in low- and middle-income countriesMarcello Tonelli, Victoria Nkunu, Cherian Varghese, et al.
Pageof 20